Newman Batanayi Madzikwa: The Systems Behind Affordable Healthcare Access

Supply chains in healthcare are about much more than procurement, logistics, and inventory. Behind every efficient system is a person who needs access to the right medicine or essential commodity at the right time and at a cost they can afford. This makes pharmaceutical supply chain management a field where operational decisions can have a direct impact on people’s lives.

It is this purpose that defines Newman Batanayi Madzikwa, Managing Director at NatPharm. As a supply chain pharmacist, Newman is passionate about ensuring that essential commodities reach end users affordably and efficiently. His experience across both the private and public sectors has shaped his belief in bringing the strengths of both environments together to address complex challenges.

His professional journey has also taken him beyond the traditional healthcare setting. During his time with the United Nations Peacekeeping Mission in Timor-Leste, where he served as a Medical Supply Officer, he gained valuable international experience in medical supply management, coordination, and leadership.

Newman’s approach extends beyond improving systems. He is passionate about helping people regain confidence and overcome challenges, particularly within the supply chain profession. He also works toward helping organisations navigate difficult economic conditions by re-engineering their supply chains and identifying activities that add little or no value. At the heart of his leadership is a practical belief that stronger, more efficient supply chains can create meaningful benefits for both organisations and the people they ultimately serve.

Below are the highlights from the interview with Newman Batanayi Madzikwa, offering insights into the experiences, values, and leadership principles that have shaped his journey. His perspective goes beyond the operational side of supply chain management, reflecting a strong focus on people, accessibility, resilience, and creating systems that deliver meaningful value across the healthcare sector.

Can you take us through your journey as a pharmacist and supply-chain professional? What led you to your current role as Managing Director at NatPharm?

My journey began with a genuine fascination for how medicines move from the laboratory bench to the patient’s hand. Training as a pharmacist gave me the clinical grounding, but it was on the operational side — procurement, warehousing, distribution — that I found my calling.

Over the years I moved between public and private-sector environments, and later served in an international peacekeeping logistics role, each posting adding a different lens on how supply chains behave under pressure. What consistently drew me forward was the realisation that a stock-out is never just a logistics failure; it is a patient who doesn’t get treated. That conviction shaped my career choices and ultimately led me to NatPharm, where the scale of impact — supplying medicines to an entire health system — matched the scale of responsibility I wanted to carry.

What role does NatPharm play in the pharmaceutical supply chain? What are the organization’s key priorities in ensuring medicines reach end users?

NatPharm sits at the centre of the national pharmaceutical supply chain, procuring, warehousing and distributing medicines and medical commodities to public health institutions across the country. Our mandate is to ensure the right medicine is in the right place, in the right quantity and quality, at the right time.

Our key priorities are threefold: strengthening procurement planning so that orders are placed against real consumption data rather than guesswork; tightening quality assurance at every receiving point, from goods verification to storage conditions; and improving last-mile distribution so that facilities furthest from our depots are not the ones that suffer most. Underlying all of this is a push towards better data visibility, because you cannot manage what you cannot see across the chain.

You are passionate about making commodities accessible at an affordable cost. What are the biggest challenges in achieving this goal, and how is NatPharm addressing them?

Affordability is constrained by a combination of foreign currency exposure, global price volatility, and the sheer cost of moving goods across a wide distribution network. When a significant share of pharmaceutical inputs is imported, exchange rate shifts alone can undo months of careful budgeting.

NatPharm addresses this through pooled procurement to secure volume-based pricing, closer collaboration with development partners and donors to align funded commodities with actual need, and a deliberate effort to reduce waste — expired or damaged stock is, in effect, money the health system cannot recover. We are also investing in better forecasting so that we buy closer to true demand, which reduces both overstocking and the emergency, premium-priced procurement that drives costs up.

What makes a pharmaceutical supply chain effective and resilient? Which areas are you focusing on to strengthen NatPharm’s supply-chain operations?

An effective supply chain is one that is visible, predictable and able to absorb shocks without collapsing service delivery. Resilience comes from redundancy in suppliers, disciplined inventory management, and systems that flag problems early rather than after stock has already run out.

At NatPharm, we are focusing on three areas: digitising our tracking of medicines from receipt to dispensing, so that discrepancies — whether data entry errors, part-deliveries or quality concerns — are caught quickly; strengthening our supplier performance monitoring, because a resilient chain depends on suppliers who deliver consistently and to specification; and improving warehousing standards to protect commodity integrity, particularly for temperature- and moisture-sensitive products. These are not glamorous interventions, but they are the ones that determine whether medicines reach patients intact.

You have experience in both public and private-sector environments. What can each sector learn from the other when it comes to supply-chain management?

The private sector tends to be sharper on efficiency metrics, cost discipline and customer responsiveness — every inefficiency shows up on a balance sheet, so there is constant pressure to optimise. The public sector, particularly in health, carries a depth of mandate and equity focus that the private sector rarely has to reckon with: decisions cannot be purely commercial when the outcome is whether a rural clinic has essential medicines.

What I have tried to bring into NatPharm is the private sector’s rigour around performance measurement and accountability, married to the public health mandate of equitable access. Each side benefits from borrowing the other’s discipline — the private sector could learn more about mission-driven resilience, and the public sector benefits enormously from tighter operational metrics.

What are some of the biggest challenges facing pharmaceutical supply chains today? How do you help organizations remain efficient during economic pressure?

Currency instability, rising freight and input costs, and increasingly complex regulatory and quality requirements are challenges facing pharmaceutical supply chains across the region, not just in our market. Add to that the pressure of growing disease burden against constrained budgets, and organisations are being asked to do more with proportionally less.

Remaining efficient under this pressure means being ruthless about waste — in stock levels, in process duplication, and in manual work that could be automated — while protecting the parts of the operation that safeguard quality and access. It also means building close, transparent relationships with suppliers and financiers, because economic pressure is best absorbed collaboratively rather than passed down the chain unilaterally.

You describe leadership as one of your default characteristics. How would you define your leadership style, and how does it shape your work at NatPharm?

I would describe my leadership style as principled and hands-on. I believe leaders should be close enough to operations to understand the real constraints their teams face, while still holding a clear line of sight on strategy and outcomes. I set high standards, but I pair that with a genuine investment in developing the people around me, because a supply chain is only as strong as the professionals running it day to day.

At NatPharm, this translates into a culture where accountability is expected but not punitive — where flagging a problem early is rewarded, not hidden for fear of blame. That openness is essential in an environment where the cost of concealed problems is ultimately borne by patients.

You served as a Medical Supply Officer with the United Nations Peacekeeping Mission in Timor-Leste. What did that experience teach you about logistics, leadership, and working under challenging conditions?

Timor-Leste was a formative experience. Operating medical logistics in a peacekeeping environment strips away the margin for error — there is no easy substitute supplier down the road, and the consequences of a broken cold chain or a missed delivery are immediate and serious. It taught me to plan with layers of contingency, to lead diverse, multinational teams through clear communication rather than assumed shared context, and to stay calm and decisive when conditions change quickly. I came away with a deep respect for logistics as a discipline in its own right, and a leadership instinct that has stayed with me since: in difficult conditions, the team looks to its leader for steadiness, not perfection.

How can technology improve pharmaceutical supply chains? Which digital capabilities do you believe can create the greatest operational impact?

Technology is central to where pharmaceutical supply chains need to go. Electronic logistics management information systems that give real-time visibility of stock across every level of the chain allow for far better forecasting, faster identification of diversion or wastage, and quicker response when shortages emerge.

At NatPharm, we have been advancing our digital transformation agenda, including piloting electronic tracking of medicines and working towards more integrated enterprise systems that link procurement, warehousing and distribution data. The capabilities I believe will create the greatest impact are end-to-end traceability from receipt to dispensing, automated alerts for expiry and stock-level thresholds, and integration between our systems and those of health facilities, so that consumption data flows back into procurement planning rather than staying trapped at the point of use.

Which supply-chain or leadership achievement has been particularly meaningful during your career? What did it teach you about solving complex challenges?

One of the achievements I remain most proud of is leading detailed diagnostic work into our receiving and quality-verification processes — the unglamorous but essential task of examining exactly what happens when commodities arrive, and where discrepancies creep in.

Uncovering issues such as data entry anomalies, part-supply gaps and quality concerns at the point of receipt, and translating that into structured, actionable reporting, taught me that complex challenges are rarely solved by a single dramatic intervention. They are solved by disciplined, granular attention to the details that others might consider too small to matter. That lesson has stayed with me: the biggest risks to a supply chain often hide in the smallest, most routine transactions.

What opportunities do you see for NatPharm in the years ahead? How can the organization continue improving efficiency, affordability, and access to essential commodities?

I see significant opportunity in deepening our digital transformation — moving from pilot initiatives to fully integrated systems that give us predictive, not just reactive, visibility of our supply chain. There is also opportunity in strengthening local and regional partnerships to reduce our exposure to long, costly import routes, and in continuing to professionalise our workforce so that the skills on the ground match the sophistication of the systems we are building.

Ultimately, the opportunity is to shift NatPharm from being purely a distribution utility to being a data-driven supply chain organisation that can anticipate need before it becomes a crisis. That shift is what will move the needle on efficiency, affordability and access simultaneously.

What principles have guided you throughout your career? How do you balance operational demands with your responsibility to people and communities?

Integrity, accountability and a bias towards service have guided me throughout my career. I have always tried to make decisions as though the patient at the end of the chain were standing in the room — because ultimately, they are the reason the work exists. Balancing operational demands with responsibility to people and communities means resisting the temptation to treat targets and numbers as ends in themselves; they are only useful insofar as they translate into medicines reaching the people who need them.

Practically, this means I insist on quality and compliance even when it is operationally inconvenient, and I try to ensure that the pressure of running a large organisation never fully eclipses the human purpose behind it.

What advice would you give professionals who want to build careers in pharmaceutical supply-chain management? Which skills will become increasingly important?

My advice is to build a strong foundation in the fundamentals — quality assurance, inventory and demand planning, procurement — before specialising, because supply chain problems rarely respect departmental boundaries. Seek out experience in different environments, public and private, local and international, because each will sharpen a different set of instincts.

Looking ahead, I believe data literacy and comfort with digital systems will become as important as technical pharmaceutical knowledge; the professionals who thrive will be those who can interpret data to anticipate problems rather than simply react to them. Equally important are the softer skills — clear communication, ethical judgement under pressure, and the resilience to keep functioning when conditions are difficult.

Ultimately, this is a field for people who want their work to matter, and it consistently does.